RT Journal Article
SR Electronic
T1 Establishing Reference Ranges for Vitamin D Levels in a Representative Population of Peshawar, Pakistan
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.02.15.24302821
DO 10.1101/2024.02.15.24302821
A1 Usama
A1 Rehman, Zeeshan
A1 Ali, Aktar
YR 2024
UL http://medrxiv.org/content/early/2024/02/17/2024.02.15.24302821.abstract
AB Background Vitamin D deficiency is prevalent in Pakistan, yet there is no consensus on the optimal range for 25-hydroxyvitamin D (25(OH)D) levels. Establishing reference ranges specific to the population is essential due to variations in age, sex, race, and diet. Parathyroid hormone (PTH) serves as a surrogate marker for vitamin D deficiency. This study aims to determine the reference range for plasma vitamin D in a healthy population in Peshawar, considering various demographic and biochemical factors.Methods A population-based cross-sectional study was conducted in four union councils of District Peshawar. Participants (n=200) aged 18-54 years underwent serum vitamin D and PTH analysis using ELISA kits. Data on sun exposure, anthropometric measurements, and dietary habits were collected.Results The majority of participants (92%) reported daily sun exposure of 15-30 minutes and had a mean BMI of 23.598±3.988 kg/m2. Only 28% of participants were vitamin D sufficient, while 72% were deficient. test results obtained for the reference values were 6.43–45.0 ng/mL for the percentile range of 2.5–97.5.Conclusion The high prevalence of vitamin D deficiency underscores the need for governmental and educational interventions to promote awareness and address this issue. Additionally, tailored nutrition plans are crucial to mitigate vitamin D deficiency in the local population.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical clearance for this study was obtained from the Ethics Review Committee of Khyber Medical University, Peshawar, Pakistan.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors